ICC Partners with CBT For Clinical Study at GCH

ICC is excited to announce its collaboration with Caribbean Biotechnologies, Inc. (CBT)  to conduct clinical studies to test CBT's new technology for the instantaneous detection of tuberculosis (TB) at Grace Children's Hospital, beginning fall 2015.

CBT technology represents a breakthrough for instant detection of airborne transmitted diseases, including TB. The system is an optical based, non-invasive instrument designed to detect active TB in seconds, compared to current methods which require days for an accurate diagnostic.  This technology has the potential to dramatically reduce rates of infection and transmission for TB.

TB  has a worldwide mortality rate of 2 million per year, according to the World Health Organization. Haiti has the highest rate of TB in the western hemisphere.  "Grace Children's Hospital was highly recommended by the US Center for Disease Control, because of their pro-active program in TB detection, and dedicated and experienced personnel," explains Dr. Jorge E. Gonzalez, President of CBT. "This proved very correct after several meetings with [ICC Haiti National Director] Dr. Bijou and her staff."

ICC has a long history of leadership in the Haitian healthcare community for the treatment/prevention of TB. We look forward to continuing this role as we collaborate with CBT to bring more effective and affordable tubercular detective technology to Haiti.

Click here to read more press coverage from Haiti Libre.